Journal of Bone and Mineral Metabolism

, Volume 10, Issue 2, pp 39–49 | Cite as

Calorie restriction increases serum parathyroid hormone and decreases serum calcitonin levels in patients with maturity onset diabetes mellitus

  • Kiyoshi Hashizume
  • Kazuo Ichikawa
  • Satoru Suzuki
  • Teiji Takeda
  • Keishi Yamauchi
  • Mutsuhiro Kobayashi
  • Xiao-Yun MA
Original Articles


Calorie restriction is important in managing patients with maturity onset diabetes mellitus (NIDDM). The effect of such restriction on calcium metabolism is not known. The objective of this study was to determine whether patients on calorie restricted diets would show any modification of parathyroid hormone (PTH) and calcitonin (CTN).

The serum levels of PTH and CTN were measured by radioimmunoassays in 269 patients with NIDDM. The patients were divided into two groups depending on the intake of calorie, and PTH and CTN were monitored for 2 years. Plasma levels of vitamin D were measured by competitive protein binding assays before and after each program.

The level of PTH (520.8±266.0 pg/ml) (mean±S.D.) was significantly (P<0.01) higher in 109 diabetic patients whose calorie intake was restricted for 2 years (diet (D) group) as compared with that (256.6±103.8 pg/ml) of 160 diabetic patients whose calorie intake was not restricted (non-diet (ND) group). The daily oral calcium intake of the two groups did not differ significantly. We found no significant difference in the serum PTH level in the ND groupVS. normal control subjects (248.8±98.4, N=78). The serum calcium concentration and the amount of calcium excreted in urine were slightly but significantly (P<0.01) lower in the D than in the ND group. The rate of tubular reabsorption of phosphate (% TRP) was significantly lower in the D group than that in the ND group (P<0.01). The serum CTN level was significantly (P<0.01) lower in the D group (33.9±11.3 pg/ml) than in the ND group (64.9±21.2 pg/ml) 2 years after each treatment. The plasma 1,25-(OH)2-vitamin D level was significantly (P<0.01) lower in the D group (22.2±6.6 pg/ml) than in the ND group (50.6±4.2 pg/ml). When the restriction of calorie intake in the D group was canceled, their PTH levels decreased, which was accompanied by increase in the 1,25-(OH)2-vitamin D levels, whereas their CTN levels were unchanged.

These observations suggested that a restricted calorie intake is a risk factor for secondary hyperparathyroidism as well as for a low serum level of CTN in patients with NIDDM.

Key Words

Maturity-onset diabetes mellitus (NIDDM) Parathyroid hormone (PTH) Calcitonin (CTN) Vitamin D Calorie restriction 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Cooppan, R. and Flood, T.M.: Obesity and Diabetes.In: Joslin's Diabetes Mellitus, 12th edition. (A. Marble, L.P. Krall, R.F. Bradley, A.R. Christlieb and J.S. Soeldner, editors), Lea & Febiger, Philadelphia. 373–379, 1985.Google Scholar
  2. 2.
    Flood, T.M., Halford, B.N., Cooppan, R. and Marble, A.: Dietary management of diabetes.In: Joslin's Diabetes Mellitus, 12th edition. (A. Mable, L.P. Krall, R.E. Bradley, A.R. Christlieb and J.S. Soeldner, editors), Lea & Febiger, Philadelphia. 357–372, 1985.Google Scholar
  3. 3.
    Fajans S.S.: Diabetes mellitus: Classification and testing procedures.In: Endocrinology, 2nd edition. (L.J. DeGroot, G.F. Cahill Jr., J.C. Marshall, D.H. Nelson, W.D. Odell, J.T. Potts Jr., A.H. Rubenstein, A.H. Steinberger, and L. Martini, editors), W.B.Saunders, Philadelphia. 1346–1356, 1989.Google Scholar
  4. 4.
    McNair. P., Madsbad, S., Christiansen, C., Christensen, M.S., Faber, O.K., Binder, C. and Transbol, I.: Bone loss in diabetes. Effects of metabolic state. Diabetologia. 17: 283–286, 1979.CrossRefPubMedGoogle Scholar
  5. 5.
    Heath III, H., Lambert, P.W., Service, F.J. and Arnaud, S.B.: Calcium homeostasis in diabetes mellitus. J. Clin. Endocrinol. Metab. 49: 462–466, 1979.PubMedGoogle Scholar
  6. 6.
    Gertner, J.M., Tamborlane, W.V., Horst, R.L., Sherwin, R.S., Felig, P. and Genel, M.: Mineral metabolism in diabetes mellitus: changes accompanying treatment with a portable subcutaneous insulin infusion system. J. Clin. Endocrenol. Metab. 50: 862–866, 1980.Google Scholar
  7. 7.
    Frazer, T.E., White, N.H., Hough, S., Santiago, J.V., McGee, B.R., Bryce, G., Mallon, J. and Avioli, L.V.: Alterations in circulating vitamin D metabolites in the young insulin-dependent diabetic. J. Clin. Endocrinol. Metab. 153: 1154–1159, 1981.Google Scholar
  8. 8.
    Witt, M.E., White, N.H., Santiago, J.V., Seino, Y. and Avioli, L.V.: Use of oral calcium loading to characterize the hypercalciuria of young insulin-dependent diabetics. J. Clin. Endocrinol. Metab. 57: 94–100, 1982.Google Scholar
  9. 9.
    Hruska, K.A., Kopelman, R., Rutherford, W.E., Klahr, S. and Slatopolosky, E.: Metabolism of immuno-reactive parathyroid hormone in the dog: The role of the kidney and the effects of chronic renal disease. J. Clin. Invest. 56: 39–48, 1975.PubMedGoogle Scholar
  10. 10.
    Haddad, J.G. and Chyu, K.J.: Competitive protein-binding radioassay for 25-hydroxycholecalciferol. J. Clin. Endocrinol. Metab. 33: 992–995, 1974.Google Scholar
  11. 11.
    Hillman, L.S., Slatopolsky, E. and Haddad, J.D.: Perinatal vitamin D metabolism. M. Maternal and cord serum 24,25-hydroxyvitamin D concentrations. J. Clin. Endocrinol. Metab. 47: 1073–1077, 1978.PubMedGoogle Scholar
  12. 12.
    Eisman, J.A., Hamstra, A.T., Kream, B.E. and DeLuca, H.F.: 1,25-dihydroxyvitamin D in biological fluids: a simplified and sensitive assay. Science 193: 1021–1023, 1976.PubMedGoogle Scholar
  13. 13.
    Menard, L., Dempsey, M.E., Blankstein, L.A., Aleyassine, H., Wacks, M. and Soeldner, J.S.: Quantitative determination of glycosylated hemoglobin A1 by agar gel electrophoresis. Clin. Chem. 26: 1598–1602, 1980.PubMedGoogle Scholar
  14. 14.
    Genant, H.K., Cann, C.E. and Bruce, E.: Quantitative computed tomography of vertebral spongiosa: A sensitive method for detecting early bone loss after oophorectomy. Annals. Int. Med. 97: 699–705, 1982.Google Scholar
  15. 15.
    Schedl, H.P., Heath III, H. and Wenger, J.: Serum calcitonin and parathyroid hormone in experimental diabetes. Endocrinology 103: 1368–1373, 1978.PubMedGoogle Scholar
  16. 16.
    Spencer, E.M., Khalli, M. and Tobiassen, O.: Experimental diabetes in the rat causes an insulin-reversible decrease in renal 25-hydroxyvitamin D3-1a-hydroxylase activity. Endocrinology 107: 300–305, 1980.PubMedGoogle Scholar
  17. 17.
    Wongsurawat, N., Armbrecht, H.J., Zenser, T.V., Davis, B.B., Thomas, M.L. and Forte, L.R.: 1,25-Dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 production by isolated renal slices as modulated by diabetes and insulin in the rat. Diabetes 32: 302–306, 1983.PubMedGoogle Scholar
  18. 18.
    Bikle, D.D., Gee, E., Halloran, B., Kowalski, M.A., Ryzen, E. and Haddad, J.G.: Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J. Clin. Endocrinol. Metab. 63: 954–959, 1986.PubMedGoogle Scholar
  19. 19.
    Vanham, G., Van Baelen, H., Tan, B.K. and Bouillon, R.: The effect of vitamin D analogs and of vitamin D-binding protein on lymphocyte proliferation. J. Steroid Biochem. 29: 381–386, 1988.CrossRefPubMedGoogle Scholar
  20. 20.
    Nyomba, B.L., Bouillon, R., Bidingija, M., Kadjingu, K. and De Moore, P.: Vitamin D metabolites and their binding protein in adult diabetic patients. Diabetes. 35: 911–915, 1986.PubMedGoogle Scholar
  21. 21.
    Reiss, E. and Canterbury, J.M.: Spectrum of hyperparathyroidism. Am. J. Med. 56: 794–799, 1974.CrossRefPubMedGoogle Scholar
  22. 22.
    Coe, F.L., Canterbury, J.M., Firpo, J.J. and Reiss, E.: Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria. J. Clin. Invest. 52: 134–142, 1973.PubMedGoogle Scholar
  23. 23.
    Mahaffey, J.E. and Potts Jr., J.T.: Secondary hyperparathyroidism: Pathophysio-logy and etiology.In: Endocrinology, first edition. (L.J. DeGroot, G.F. Cahill, and W.D. Odell, eds.) New York: Grune and Stratton, 739–749, 1979.Google Scholar
  24. 24.
    Buckle, R.M., Aurbach, G.D. and Potts Jr., J.T.: Adaptive increases in parathyroid glandular activity.In: Protein and Polypeptide Hormones. Excerpta Medica International Congress Series No. 161. Amsterdam, Excepta Medica, 389–395, 1969.Google Scholar
  25. 25.
    Mayer, G.P., Habener, J.F. and Potts Jr., J.T.: Parathyroid hormone secretion invivo: Demonstration of a calcium-independent, nonsuppressible component of secretion. J. Clin. Invest. 57: 678–683, 1976.PubMedGoogle Scholar
  26. 26.
    Willis, M.R., Pak, C.Y.C., Hammond, W.G. and Bartter, F.C.: Normocalcemic primary hyperparathyroidism. Am. J. Med. 47: 384–391, 1969.Google Scholar
  27. 27.
    Dietel, M., Dorn, G., Montz, R. and Altenahr, E.: Influence of vitamin D3, 1,25-dihydroxyvitamin D3, and 24,25-dihydroxyvitamin D3 on parathyroid hormone secretion, adenosine 3′,5′-monophosphate release, and ultrastructure of parathyroid glands in organ culture. Endocrinology 105: 237–245, 1979.PubMedGoogle Scholar
  28. 28.
    Chertow, B.S., Baker, G.R., Henry, H.L. and Norman, A.W.: Effects of vitamin D metabolites on bovine parathyroid hormone release in vitro. Am. J. Physiol. 238: E384-E387, 1980.PubMedGoogle Scholar
  29. 29.
    Cantley, L.K., Russell, J., Lettieri, D. and Sherwood, L.M.: 1,25-dihydroxyvitamin D3 suppresses parathroid hormone secretion from bovine parathyroid cells in tissue culture. Endocrinology 117: 2114–2119, 1985.PubMedGoogle Scholar
  30. 30.
    Delmez, J.A., Tindira, C., Groom, P., Dusto, A., Windus, D.W. and Slatopolsky, E.: Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium. J. Clin. Invest. 83: 1349–1355, 1989.PubMedGoogle Scholar
  31. 31.
    Wiske, P.S., Epstein, S., Bell, N.H., Queener, S.F., Edmondson, J., Johnston Jr., C.C.: Increases in immunoreactive parathyroid hormone with age. N. Engl. J. Med. 300: 1419–1421, 1979.PubMedGoogle Scholar
  32. 32.
    Insogna, K.L., Lewis, A.M., Lipinski, B.A., Bryant, C. and, Baran, D.T.: Effect of age on serum immunoreactive parathyroid hormone and its biological effects. J. Clin. Endocrinol. Metab. 53: 1072–1075, 1981.PubMedGoogle Scholar
  33. 33.
    Marcus, R., Madvig, P. and Young, G.: Age-related changes in parathyroid hormone and parathyroid hormone action in normal humans. J. Clin. Endoccrinol. Metab. 58: 223–230, 1984.Google Scholar
  34. 34.
    Copp, D.H., Cameron, E.C., Cheney, B.A., Davidson, A.G.F. and Henze, K.G.: Evidence for calcitonin — a new hormone from the parathyroid that lowers blood calcium. Endocrinology 70: 638–649, 1962.PubMedGoogle Scholar
  35. 35.
    Kumar, M.A., Foster, G.V. and MacIntyre, I.: Further evidence for calcitonin, a rapid-acting hormone which lowers plasma calcium. Lancet 2: 480–482, 1963.Google Scholar
  36. 36.
    Austin, L.A. and Heath III, H.H.: Calcitonin: Physiology and pathophysiology. N. Engl. J. Med. 304: 269–278, 1981.PubMedGoogle Scholar
  37. 37.
    Chambers, T.J. and Moore, A.: The sensitivity of isolated osteoclasts to morphological transformation by calcitonin. J. Clin. Endocrinol. Metab. 57: 819–824, 1983.PubMedGoogle Scholar
  38. 38.
    Milhaud, G., Benezech-Lefevre, M. and Moukhtar, M.S.: Deficiency of calcitonin in age related osteoporosis. Biomedicine 29: 272–276, 1978.PubMedGoogle Scholar
  39. 39.
    Taggart, H., Chesnut III, C.H., Ivey, J.L., Baylink, D.J., Sisom, K. and Hubber, M.B.: Deficient calcitonin response to calcium stimulation in postmenopausal osteoporosis? Lancet 1: 475–478, 1982.PubMedGoogle Scholar
  40. 40.
    Stevenson, J.C.: Regulation of calcitonin and parathyroid hormone secretion by estrogens. Meturitas 4: 1–7, 1982.Google Scholar
  41. 41.
    Deftos, L.J., Weisman, M.H., Williams, G.W., Karph, D.B., Frumar, A.M., Davidson, B.J., Parthemore, J.G. and Judd, H.L.: Influence of age and sex on plasma calcitonin in human beings. N. Engl. J. Med. 302: 1351–1353, 1980.PubMedGoogle Scholar
  42. 42.
    Nyomba, B.L., Verhaeghe, J., Thomasset, M., Lissens, W. and Buoillon, R.: Bone mineral homeostasis in spontaneously diabetic BB rats. I. Abnormal vitamin D metabolism and impaired active intestinal calcium absorption. Endocrinology 124: 565–572, 1989.PubMedGoogle Scholar
  43. 43.
    Verhaeghe, J., Suiker, A.M.H., Nyomba, B.L., Visser, W.J., Einhorn, T.A., Dequeker, J. and Bouillon, R.: Bone mineral homeostasis in spontaneously diabetic BB rats. II. Impaired bone turnover and decreased osteocalcin synthesis. Endocrinology 124: 573–582, 1989.PubMedGoogle Scholar

Copyright information

© Japanese Society of Bone Metabolism Research 1992

Authors and Affiliations

  • Kiyoshi Hashizume
    • 1
  • Kazuo Ichikawa
    • 1
  • Satoru Suzuki
    • 1
  • Teiji Takeda
    • 1
  • Keishi Yamauchi
    • 1
  • Mutsuhiro Kobayashi
    • 1
  • Xiao-Yun MA
    • 1
  1. 1.Department of Geriatrics, Endocrinology and MetabolismShinshu University School of MedicineMatsumotoJapan

Personalised recommendations